Department of Haematology, University College London (UCL) Cancer Institute, London, UK.
Br J Haematol. 2020 Nov;191(4):552-557. doi: 10.1111/bjh.17154.
At the time of the formation of the British Society of Haematology diffuse large B-cell lymphoma was not recognised as a specific entity and was included in the category of 'large cell' or 'aggressive' lymphomas. These were fatal in 95% of cases. Today the cure rate in adults entered into clinical trials is ~70% and a large number of British physicians have contributed to this progress.
在英国血液学学会成立之时，弥漫性大 B 细胞淋巴瘤并未被视为一种特定的实体，而是归入“大细胞”或“侵袭性”淋巴瘤类别。这些淋巴瘤在 95%的病例中是致命的。如今，进入临床试验的成人治愈率约为 70%，许多英国医生为此做出了贡献。
